Review



male primary hpasmc cell line  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Lonza male primary hpasmc cell line
    Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell <t>(hPASMC)</t> <t>proliferation</t> in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.
    Male Primary Hpasmc Cell Line, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/male primary hpasmc cell line/product/Lonza
    Average 90 stars, based on 1 article reviews
    male primary hpasmc cell line - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1"

    Article Title: Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    doi: 10.1152/ajplung.00057.2017

    Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell (hPASMC) proliferation in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.
    Figure Legend Snippet: Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell (hPASMC) proliferation in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.

    Techniques Used: Over Expression, Staining, TUNEL Assay, Control



    Similar Products

    primary cell lines of hpasmcs  (Procell Inc)
    90
    Procell Inc primary cell lines of hpasmcs
    Primary Cell Lines Of Hpasmcs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary cell lines of hpasmcs/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    primary cell lines of hpasmcs - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    male primary hpasmc cell line  (Lonza)
    90
    Lonza male primary hpasmc cell line
    Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell <t>(hPASMC)</t> <t>proliferation</t> in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.
    Male Primary Hpasmc Cell Line, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/male primary hpasmc cell line/product/Lonza
    Average 90 stars, based on 1 article reviews
    male primary hpasmc cell line - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    primary hpasmc cell line cc-2581  (Lonza)
    90
    Lonza primary hpasmc cell line cc-2581
    Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell <t>(hPASMC)</t> <t>proliferation</t> in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.
    Primary Hpasmc Cell Line Cc 2581, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary hpasmc cell line cc-2581/product/Lonza
    Average 90 stars, based on 1 article reviews
    primary hpasmc cell line cc-2581 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    a primary hpasmc cell line  (Lonza)
    90
    Lonza a primary hpasmc cell line
    Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell <t>(hPASMC)</t> <t>proliferation</t> in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.
    A Primary Hpasmc Cell Line, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a primary hpasmc cell line/product/Lonza
    Average 90 stars, based on 1 article reviews
    a primary hpasmc cell line - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    primary hpasmc cell line  (Lonza)
    90
    Lonza primary hpasmc cell line
    Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell <t>(hPASMC)</t> <t>proliferation</t> in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.
    Primary Hpasmc Cell Line, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary hpasmc cell line/product/Lonza
    Average 90 stars, based on 1 article reviews
    primary hpasmc cell line - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell (hPASMC) proliferation in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1

    doi: 10.1152/ajplung.00057.2017

    Figure Lengend Snippet: Micro-RNA-1 (miR-1) overexpression inhibits human pulmonary artery smooth muscle cell (hPASMC) proliferation in normoxia and hypoxia. Overexpression of miR-1 mimics in hPASMCs (50–100 nmol/l) significantly reduces proliferation in normoxia (A) and hypoxia (3% O2, 24–48 h; B). C and D: representative images of hPASMCs demonstrating miR-1 mimic overexpression in normoxia and hypoxia reduces the rate of proliferation (24 h, ×10 magnification). Representative staining images (E) and quantification of terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay (F) demonstrating induction of apoptosis at low levels by overexpression of miR-1 mimics (100 nmol/l) in hPASMCs (24 h, ×10 magnification). Data are represented as percentage of TUNEL-positive cells of total 4′,6-diamidino-2-phenylindole (DAPI)-positive cells per high-power field per condition (≥5 fields counted). Here, n ≥ 5 per condition. **P < 0.01, ***P < 0.001 relative to control (Ctrl). BrdU, 5-bromo-2′-deoxyuridine.

    Article Snippet: In addition to these cell lines, a male primary hPASMC cell line from Lonza (CC-2581) was used for cell transfection, migration, and proliferation assays at passages 4–8 .

    Techniques: Over Expression, Staining, TUNEL Assay, Control